These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38510448)

  • 1. Podocyte number and glomerulosclerosis indices are associated with the response to therapy for primary focal segmental glomerulosclerosis.
    de Zoysa N; Haruhara K; Nikolic-Paterson DJ; Kerr PG; Ling J; Gazzard SE; Puelles VG; Bertram JF; Cullen-McEwen LA
    Front Med (Lausanne); 2024; 11():1343161. PubMed ID: 38510448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
    Hirakawa M; Tsuruya K; Yotsueda H; Tokumoto M; Ikeda H; Katafuchi R; Fujimi S; Hirakata H; Iida M
    Life Sci; 2006 Jul; 79(8):757-63. PubMed ID: 16564554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.
    Zhang J; Pippin JW; Krofft RD; Naito S; Liu ZH; Shankland SJ
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1375-89. PubMed ID: 23486009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.
    Chang JW; Pardo V; Sageshima J; Chen L; Tsai HL; Reiser J; Wei C; Ciancio G; Burke GW; Fornoni A
    Transplantation; 2012 Jun; 93(12):1238-44. PubMed ID: 22499148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
    Kim JS; Han BG; Choi SO; Cha SK
    Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
    Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
    Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
    Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
    BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study.
    Chiang ML; Hawkins EP; Berry PL; Barrish J; Hill LL
    Clin Nephrol; 1988 Jul; 30(1):8-14. PubMed ID: 3061695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.
    Alachkar N; Wei C; Arend LJ; Jackson AM; Racusen LC; Fornoni A; Burke G; Rabb H; Kakkad K; Reiser J; Estrella MM
    Transplantation; 2013 Oct; 96(7):649-56. PubMed ID: 23842190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular Density and Volume in Renal Biopsy Specimens of Children with Proteinuria Relative to Preterm Birth and Gestational Age.
    Koike K; Ikezumi Y; Tsuboi N; Kanzaki G; Haruhara K; Okabayashi Y; Sasaki T; Ogura M; Saitoh A; Yokoo T
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):585-590. PubMed ID: 28336816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
    Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
    Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
    Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
    Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
    Schwartz MM
    Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amount and selectivity of proteinuria may predict the treatment response in post-transplant recurrence of focal segmental glomerulosclerosis: a single-center retrospective study.
    Ban H; Miura K; Kaneko N; Shirai Y; Yabuuchi T; Ishizuka K; Chikamoto H; Akioka Y; Shimizu S; Ishida H; Tanabe K; Hattori M
    Pediatr Nephrol; 2021 Aug; 36(8):2433-2442. PubMed ID: 33538912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal segmental glomerulosclerosis and renal transplantation.
    Crosson JT
    Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nonspecificity of focal segmental glomerulosclerosis. The defining characteristics of primary focal glomerulosclerosis, mesangial proliferation, and minimal change.
    McAdams AJ; Valentini RP; Welch TR
    Medicine (Baltimore); 1997 Jan; 76(1):42-52. PubMed ID: 9064487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.